TURKISH JOURNAL OF PATHOLOGY, cilt.34, sa.3, ss.199-206, 2018 (ESCI İndekslerine Giren Dergi)
Objective: Although classical Hodgkin lymphoma (c H L) has a relatively good prognosis, it also entails different treatment responses and involves patients who have different clinical courses. Our aim was to investigate c-Myc, Bcl-2 and EBV biomarkers in cHL and their relationship with the IPS score.